Expression and clinical significance of microvessel density and its association with TWIST in nasopharyngeal carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 1265-1270

  Zhuo, Xianlu ^a,b   Chang, Aoshuang ^b   Huang, Chuang ^a   Yang, Li ^b   Xiang, Zhaolan ^c   Zhou, Yan ^c  

^a Chongqing Cancer Institute   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Expression; Inmmunohistochemistry; Microvessel density; Nasoparyangeal carcinoma; TWIST

Indexed keywords

CD34 ANTIGEN; TRANSCRIPTION FACTOR TWIST;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CAPILLARY DENSITY; CLINICAL FEATURE; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION;

EID: 84923061736     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kontos CK, Fendri A, Khabir A, Mokdad-Gargouri R and Scorilas A. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study. BMC Cancer 2013; 13: 293.
2. Mao CG, Tao ZZ, Wan LJ, Han JB, Chen Z and Xiao BK. The efficacy of traditional Chinese Medicine as an adjunctive therapy in nasopharyngeal carcinoma: a systematic review and meta-analysis. J BUON 2014; 19: 540-548.
3. Dimova I, Popivanov G and Djonov V. Angiogenesis in cancer - general pathways and their therapeutic implications. J BUON 2014; 19: 15-21.
4. Bonapace L, Coissieux MM, Wyckoff J, Mertz KD, Varga Z, Junt T and Bentires-Alj M. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 2014; 515: 130-133.
5. Raica M, Cimpean AM and Ribatti D. Angiogenesis in pre-malignant conditions. Eur J Cancer 2009; 45: 1924-1934.
6. Wang HL and Zhang ZL. Analysis of the relationship between ultrasound of breast cancer DOT-SDI and the expression of MVD, VEGF and HIF-1alpha. Cell Biochem Biophys 2014; 70: 205-208.
7. Badescu A, Georgescu CV, Vere CC, Craitoiu S and Grigore D. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer. Rom J Morphol Embryol 2012; 53: 997-1005.
8. Sundov Z, Tomic S, Alfirevic S, Sundov A, Capkun V, Nincevic Z, Nincevic J, Kunac N, Kontic M, Poljak N and Druzijanic N. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer. Hepato-gastroenterology 2013; 60: 432-438.
9. Gacche RN and Meshram RJ. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. Biochim Biophys Acta 2014; 1846: 161-179.
10. Wendt MK, Balanis N, Carlin CR and Schiemann WP. STAT3 and epithelial-mesenchymal transitions in carcinomas. JAKSTAT 2014; 3: e28975.
11. Kim K, Park EY, Yoon MS, Suh DS, Kim KH, Lee JH, Shin DH, Kim JY, Sol MY and Choi KU. The Role of TWIST in Ovarian Epithelial Cancers. Korean J Pathol 2014; 48: 283-291.
12. Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S and Sakai H. High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma. Int J Clin Exp Pathol 2014; 7: 3158-3165.
13. Wang N, Luo HJ, Yin GB, Dong CR, Xu M, Chen GG and Liu ZM. Overexpression of HIF-2alpha, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma. Clin Dev Immunol 2013; 2013: 589423.
14. Gao XH, Yang XQ, Wang BC, Liu SP and Wang FB. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac J Cancer Prev 2013; 14: 5055-5060.
15. Sanchez-Tillo E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A and Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012; 69: 3429-3456.
16. Weidner N, Semple JP, Welch WR and Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
17. Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la Taille A, Katz AE, Olsson CA and Ennis RD. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 1999; 53: 542-547.
18. Anannamcharoen S and Nimmanon T. Study of the vascular endothelial growth factor (VEGF) expression and microvascular density (MVD) in primary colorectal cancer specimens. J Med Assoc Thai 2012; 95: 1041-1047.
19. Shin DY, Jang KS, Kim BY, Choi JE, Yoon H, Ko YH and Jeong HS. Comparison of adenoid cystic carcinomas arising from the parotid gland vs. the submandibular gland: focus on systemic metastasis and tumor-associated blood vessels. J Oral Pathol Med 2014; 43: 441-447.
20. Fujii T, Sutoh T, Morita H, Yajima R, Yamaguchi S, Tsutsumi S, Asao T and Kuwano H. Vascular invasion, but not lymphatic invasion, of the primary tumor is a strong prognostic factor in patients with colorectal cancer. Anticancer Res 2014; 34: 3147-3151.
21. Fujii T, Yajima R, Hirakata T, Miyamoto T, Fujisawa T, Tsutsumi S, Ynagita Y, Iijima M and Kuwano H. Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer. Anticancer Res 2014; 34: 1255-1259.
22. Song LB, Liao WT, Mai HQ, Zhang HZ, Zhang L, Li MZ, Hou JH, Fu LW, Huang WL, Zeng YX and Zeng MS. The clinical significance of twist expression in nasopharyngeal carcinoma. Can-cer Lett 2006; 242: 258-265.
23. Gonzalez DM and Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014; 7: re8.
24. Low-Marchelli JM, Ardi VC, Vizcarra EA, van Rooijen N, Quigley JP and Yang J. Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 2013; 73: 662-671.
25. Che N, Zhao XL, Sun T, Zhao XM, Gu Q, Dong XY, Zhao N, Liu YR, Yao Z and Sun BC. The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study. Hum Pathol 2011; 42: 840-847.
26. Wallerand H, Robert G, Pasticier G, Ravaud A, Ballanger P, Reiter RE and Ferriere JM. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol 2010; 28: 473-479.
27. da Silva BB, Lopes-Costa PV, dos Santos AR, de Sousa-Junior EC, Alencar AP, Pires CG and Rosal MA. Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer. Eur J Gynaecol Oncol 2009; 30: 285-288.